Together we can meet, together we can start: YEERAN and Huilin Zegu reached a strategic cooperation and inaugurated the Joint Laboratory of Small Animal Ultrasound Imaging!
Release time:
2023-09-08
Ltd. and Beijing Huilin Zegu Biotechnology Co., Ltd. reached a strategic cooperation on September 7, 2023, and set up a joint laboratory for ultrasound imaging of small animals, and held a signing and unveiling ceremony.
Group photo of Mr. Yang (left) and Mr. Pang (right) of YEERAN signing the strategic cooperation agreement.
YEERAN is a leading company in the field of life sciences, providing a full range of solutions for animal experiments with innovation and quality as its core concepts; Huilin Zegu is a biotechnology company integrating new drug efficacy research and medical device evaluation.
The establishment of the joint laboratory will provide an excellent opportunity for us to jointly explore new ideas and methods in the field of small animal ultrasound imaging. By integrating the scientific resources and technological advantages of both parties, we will work together to provide high-quality solutions for scientific research in the fields of cardiovascular system diseases, neurological diseases, tumor diseases, and metabolic diseases.
Beijing Huilin Zegu Biotechnology Co.
|
Located in Yizhuang International Biomedical Park, Beijing Huilin Zegu Biotechnology Co., Ltd. is a biotechnology company integrating new drug efficacy research and medical device evaluation. The main business covers: ① Innovative drug candidate screening and pharmacological efficacy evaluation ② Preclinical research and evaluation of medical devices ③ Pharmacokinetic study of innovative drugs ④ Early toxicology evaluation of innovative drugs ⑤ Documentation of new drug application We have rich experience and multi-faceted models in the field of therapeutic drug development for neurological diseases, and we have also built multi-faceted systematic in-vivo and ex-vivo drug efficacy evaluation platforms for anti-tumor, metabolic diseases, cardiovascular diseases, digestive diseases, and experimental platforms for behavioral, molecular biology, pathology, and pathogenic microbiology. |
Based on the principles of openness, cooperation and win-win situation, YEERAN and Huilin Zegu will share research results and exchange academic ideas through the joint laboratories to continuously improve and enhance the scientific research capability and provide high-quality service solutions for our users.
Related News
